Allergen specific immunotherapy and management of   follow - up visits for respiratory diseases in children

doi:10.7504/ek2015010610

Abstract

Abstract:

Abstract：The long-term and preventive efficacies of ASIT have been paid great attention recently. To target the efficacy of ASIT，we may focus on：the standardizations of the treatment，patient selection，standardized allergen vaccines，management of adverse reactions，patient education， documentations and management of follow-up visits.

Key words: children, respiratory diseases, allergen specific immunotherapy（ASIT）, follow-up visits

摘要：

规范特异性免疫治疗相关要素、加强规范化患者选择、应用标准化疫苗、对不良反应安全管理、对患者和监护人教育以及建立脱敏档案和随访等，以达到治疗过敏性疾病预期目标。

关键词: 儿童, 呼吸道过敏, 变应原特异性免疫治疗, 随访管理

CLC Number:

Ｒ72

CHEN Shi，ZENG Xia，WANG Ling.. Allergen specific immunotherapy and management of follow - up visits for respiratory diseases in children[J]. Acta Metallurgica Sinica, DOI: 10.7504/ek2015010610.

陈实，曾霞，王灵. 儿童呼吸道过敏疾病特异性免疫治疗及随访管理[J]. 中国实用儿科杂志, DOI: 10.7504/ek2015010610.

References

[1］ Bousquet J， Lockey R， Malling HJ. Allergen immunotherapy:therapeutic vaccines for allergic diseases. A WHO position paper［J］. J Allergy Clin Immunol，1998，102（4 Pt 1）：558-562.

[2］ Canonica GW， Bousquet J， Casale T， et al. Sublingual immunotherapy：World Allergy Organization position paper 2009［J］. Allergy ，2009，64（suppl 91）：1-59.

[3］ Canonica GW，Cox L，Pawnkar R，et al. Sublingual immunotherapy：World Allergy Organization position paper 2013 update［J］. Word Allergy Organ J，2014，7（1）：6 .

[4］ Bousquet J，Khaltaev N，Cruz A，et al. Allergic rhinitis and its impact on asthma （ARIA） 2008 update （in collaboration with the World Health Organization， GA（2）LEN and Allergen）［J］. Allergy，2008，63（86）：8-160.

[5］ Brozek JL，Bousquet J， Carlos E，et al. Allergic rhinitis and its impact on asthma （ARIA） guidelines： 2010 revision［J］. J Allergy Clin Immunol，2010，126（3）：466-476.

[6］ Li J，Sun B，Huang Y，et al.China Alliance of Research on Respiratory Allergic Disease （CARRAD）：a multicenter study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China［J］.Allergy，2009，64：1083-1092.

[7］陈实，王灵，陈冰，等. 海南儿童哮喘常见吸入性过敏原的调查研究［J］. 临床儿科杂志，2011，29（6）：552-555.

[8］中华耳鼻咽喉头颈外科杂志编委会鼻科组，中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎特异性免疫治疗专家共识［J］. 中华耳鼻咽喉头颈外科杂志，2011，46（12）：976-980.

[9］ Vita D，Caminiti L，Ruggeri P，et al. Sublingual immunotherapy： adherence based on timing and monitoring control visits［J］. Allergy，2010，65（5）：668-669.

[10］张颖，肖琼，宋瑜欣，等. 标准化屋尘螨疫苗治疗屋尘螨过敏性支气管哮喘疗效研究［J］.中国实用儿科杂志，2011，26（10）：782-784.

[11］ Bousquet J，Heinzerling L，Bachert C，et al. Practical guide to skin prick tests in allergy to aeroallergens［J］. Allergy，2012，67（1）：18-24.

[12］李靖，孔维佳，林江涛，等. 中国特异性免疫治疗的临床实践专家共识［J］. 中华结核和呼吸杂志，2012，35（3）：163-166.

[13］ Rodriguez PN，Ambriz MMJ. Safety of immunotherapy and skin tests with allergens in children younger than five years［J］. Rev Alerg Mex，2006， 53：47-51.

[14］ Rodriguez SO.Sublingual immunotherapy in allergic rhinitis and asthma in 2-5 year-old children sensitized to mites［In Spanish］［J］.Rev Alerg Mex，2008，55：71-75.

[15］ Agostinis F，Tellarini L，Canonica GW，et al. Safety of sublingual immunotherapy with a monomeric allergoid in very young children［J］ . Allergy，2005，60：133-135.

[16］ Pajno GB，Caminiti L，Crisafulli G，et al.Adherence to sublingual immunotherapy in preschool children［J］. Pediatr Allergy Immunol，2012， 23：688-689.

[17］曹兰芳，陆权，顾洪亮，等. 舌下含服粉尘螨滴剂治疗儿童过敏性哮喘和变应性鼻炎的临床评价［J］. 中华儿科杂志，2007，45（10）：736-741.

[18］ Calderon MA，Cox L，Casale TB，et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients： looking at the published evidence［J］. J Allergy Clin Immunol，2012，129（4）：929-934.

[19］陈伯亚，龙自铭，黄燕君，等. 舌下含服粉尘螨滴剂治疗单一和多重过敏变应性鼻炎患者的临床疗效评估［J］. 中华耳鼻咽喉头颈外科杂志，2013，48（7）：549-554.

[20］肖晓雄，黄东明，崔碧云，等. 屋尘螨脱敏治疗对变应性鼻炎及哮喘患者血清粉尘螨特异性IgG4抗体的影响［J］. 中华临床免疫和变态反应杂志，2009，3（1）：34-38.

[21］ Wang L，Yin J，Fadel R，et al. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate，persistent asthma［J］. Allergy， 2014，69（9）：1181-1188.

[22］ Shao J，Cui YX，Zheng YF，et al. Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis［J］. Am J Rhinol Allergy，2014，28（2）：131-139.

[23］ Calderon MA，van Gerth WR，Eichler I，et al. Perspectives on allergen-specific immunotherapy in childhood： an EAACI position statement［J］. Pediatr Allergy Immunol，2012，23（4）：300-306.

[24］ Heale R. Short term coseasonal sublingual immunotherapy reduced the development of asthma in children with hay fever［J］. Evid Based Nurs，2005，8（2）：44.

[25］ Marogna M，Tomassetti D，Bernasconi A，et al. Preventive effects of sublingual immunotherapy in childhood： an open randomized controlled study［J］. Ann Allergy Asthma Immunol，2008，101（2）：206-211.

[26］ Marogna M，Spadolini I，Massolo A，et al. Long-lasting effects of sublingual immunotherapy according to its duration：a 15-year prospective study［J］. J Allergy Clin Immunol，2010，126（5）：969-975.

[27］ Blumberga G，Groes L，Dahl R. SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma［J］. Allergy，2011，66：178-185.

[28］ Di Rienzo V，Marcucci F，Puccinelli P，et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite：a 10-year prospective study［J］. Clin Exp Allergy，2003，33（2）：206-210.

[29］崔珑，王智楠，徐忠强，等. 舌下特异性免疫治疗不同年龄组儿童变应性鼻炎的长期疗效及安全性观察［J］. 中华耳鼻咽喉头颈外科杂志，2013，48（1）：17-21.

[30］陈建军，孔维佳，项济生，等. 舌下含服免疫治疗依从性分析及对策［J］. 临床耳鼻咽喉头颈外科杂志，2010，24（5）：203-206.

[31］吴谨准，杨运刚，张建民，等. 儿童哮喘控制测试的应用研究［J］. 中国实用儿科杂志,2011，26（4）：254-257.

[1]	LI Chang-chang, LIN Li, LI Hai-yan, et al. Research progress in the relationship between particulate matter and respiratory diseases in children and the related pathogenesis [J]. Chinese Journal of Practical Pediatrics, 2021, 36(9): 710-713.
[2]	CUI Fei-fei，CHEN Chao，LIU Jing，et al. Distribution of central sleep apnea in children with obstructive sleep apnea hypopnea syndrome [J]. CJPP, 2021, 36(6): 459-462.
[3]	ZHENG Bao-ying，CAO Ling. Paying attention to the reasonable choice of treatment mode for respiratory diseases in children [J]. CJPP, 2021, 36(3): 170-173.
[4]	CHANG Li. Physiological basis of treatment for respiratory diseases in children [J]. CJPP, 2021, 36(3): 188-190.
[5]	HAN Yu-ling，CHENG Lu. Oxygen therapy for respiratory diseases in children [J]. CJPP, 2021, 36(3): 193-199.
[6]	XU Jing*，WANG Xiao-qiu，LI Wen-xiu，et al. A cross-sectional survey and analysis of childhood allergic diseases in two communities of Yangpu District，Shanghai [J]. CJPP, 2020, 35(9): 722-726.
[7]	DU Yu-hui*，LI Jing，LIU Cheng-jun. Relationship between glycaemic variability and outcomes in critically ill children at different age [J]. CJPP, 2020, 35(6): 471-477.
[8]	ZENG Hui-qin，HU Zhi-fan，WU Jin-zhun. Study on distribution of children’s laryngopharyngeal reflux in respiratory diseases [J]. CJPP, 2020, 35(3): 233-236.
[9]	LIU Xi-cheng. History, present situation and prospect of interventional respiratory diseases in pediatrics [J]. CJPP, 2019, 34(6): 466-469.
[10]	WANG Zhong-tao，SHI Yong-sheng. Application of rapid on-site evaluation in contemporary pediatric interventional respiratory diseases [J]. CJPP, 2019, 34(6): 470-475.
[11]	CHEN Min，ZHONG Li-li. Application of TBNA in modern pediatric interventional respiratory diseases [J]. CJPP, 2019, 34(6): 490-493.
[12]	ZHU Chun-mei， ZHANG Yi. Application of balloon dilatation in modern pediatric interventional respiratory diseases [J]. CJPP, 2019, 34(6): 497-500.
[13]	WANG Xian-zhu，LI Jiu-jun. Risk factors of purulent meningitis complicated with subdural effusion in infants and young children [J]. CJPP, 2019, 34(5): 410-413.
[14]	GUO Jiang-bo，LUO You-you. Macroamylasemia in one child and the literature review [J]. CJPP, 2019, 34(4): 315-316.
[15]	SHEN Kun-ling*，SHANG Yun-xiao，ZHANG He，et al. A multicenter，randomised，controlled clinical study on efficacy and safety of recombinant human interferon α2b spray（P.putida） in treatment of acute upper respiratory tract infection in children [J]. CJPP, 2019, 34(12): 1010-1016.

Allergen specific immunotherapy and management of follow - up visits for respiratory diseases in children

儿童呼吸道过敏疾病特异性免疫治疗及随访管理

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics